• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[能否提高患者对他汀类药物治疗的长期依从性?]

[Is it possible to improve long-term compliance of patients to statin therapy?].

作者信息

Soška Vladimír, Kyselák Ondřej

出版信息

Vnitr Lek. 2017 Fall;63(10):663-666.

PMID:29127749
Abstract

Statins are key drugs for patients in secondary prevention of cardiovascular disease, as well as for primary prevention patients at high or very high risk of fatal cardiovascular events. However, long-term compliance of patients to statin therapy is relatively low, decreasing with the time of statin use; moreover a significant proportion of patients stop statins medication over the course of several years. To the early termination of statin treatment often contributes apprehension of the occurence of statin´s side effects (i.g. increased creatine kinase in the blood and muscle problems), although these symptoms are usually not causally related to statin therapy. To the low compliance may also contribute administration of statins in the evening hours, as well as the fear of developing diabetes or drug interactions. The above issues are discussed in the text of this article.Key words: compliance - creatinkinase - diabetes mellitus -LDL-cholesterol - statins.

摘要

他汀类药物是心血管疾病二级预防患者以及发生致命心血管事件高风险或极高风险的一级预防患者的关键药物。然而,患者对他汀类药物治疗的长期依从性相对较低,且随他汀类药物使用时间的延长而降低;此外,相当一部分患者在数年的疗程中停止服用他汀类药物。他汀类药物治疗早期终止往往是由于担心出现他汀类药物的副作用(如血液中肌酸激酶升高和肌肉问题),尽管这些症状通常与他汀类药物治疗没有因果关系。他汀类药物在夜间给药以及对患糖尿病或药物相互作用的恐惧也可能导致依从性较低。本文将讨论上述问题。关键词:依从性 - 肌酸激酶 - 糖尿病 - 低密度脂蛋白胆固醇 - 他汀类药物

相似文献

1
[Is it possible to improve long-term compliance of patients to statin therapy?].[能否提高患者对他汀类药物治疗的长期依从性?]
Vnitr Lek. 2017 Fall;63(10):663-666.
2
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?他汀类药物用于一级预防的理由:一项评估瑞舒伐他汀的干预试验(JUPITER)——C反应蛋白能否用于指导一级预防中的他汀类药物治疗?
Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1.
3
How do we improve patient compliance and adherence to long-term statin therapy?我们如何提高患者对长期他汀类药物治疗的依从性?
Curr Atheroscler Rep. 2013 Jan;15(1):291. doi: 10.1007/s11883-012-0291-7.
4
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
5
[Statins with a perspective of lifelong therapy].[着眼于终身治疗的他汀类药物]
Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:29-36.
6
Statin drug interactions and related adverse reactions.他汀类药物相互作用及相关不良反应。
Expert Opin Drug Saf. 2012 Nov;11(6):933-46. doi: 10.1517/14740338.2012.712959. Epub 2012 Aug 7.
7
Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.平衡一级预防与他汀类药物所致糖尿病的预防
Am J Cardiol. 2017 Oct 1;120(7):1122-1128. doi: 10.1016/j.amjcard.2017.06.054. Epub 2017 Jul 14.
8
Statin-associated incident diabetes: a literature review.他汀类药物相关的新发糖尿病:文献综述
Consult Pharm. 2014;29(5):317-34. doi: 10.4140/TCP.n.2014.317.
9
Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.美国 USE 调查中他汀类药物依从性、转换和停药的预测因素:了解美国他汀类药物的使用情况和患者教育中的差距。
J Clin Lipidol. 2013 Sep-Oct;7(5):472-83. doi: 10.1016/j.jacl.2013.03.001. Epub 2013 Mar 13.
10
Statin Prescribing in the Elderly: Special Considerations.老年人他汀类药物的处方:特殊考量
Curr Atheroscler Rep. 2017 Oct 11;19(11):47. doi: 10.1007/s11883-017-0683-9.